Olmesartan + Hctz Mylan (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan + Hctz Mylan, is an angiotensin II receptor blocker (ARB) presented as a tablet for oral use. It treats hypertension, either alone or in combination with a thiazide diuretic, in adult patients. GNH USA supplies Olmesartan + Hctz Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

GNH USA supplies Olmesartan + Hctz Mylan as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan + Hctz Mylan is an antihypertensive medication that acts on the renin‑angiotensin‑aldosterone system to lower blood pressure. - Hypertension: Reduces systolic and diastolic blood pressure in patients with primary hypertension. - Hypertension with fluid retention: Provides additional diuretic effect to control blood pressure when edema is present. - High‑risk cardiovascular patients: Lowers the risk of stroke and myocardial infarction associated with uncontrolled hypertension.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue - Cough - Increased urination - Electrolyte disturbances (e.g., low potassium)

Serious or Rare Side Effects: - Severe hypotension - Acute kidney injury - Hyperkalemia - Angio‑edema - Liver function abnormalities - Blood cell disorders such as agranulocytosis

Olmesartan + Hctz Mylan should be used with caution in patients with renal or hepatic impairment, and dose adjustments may be required. - Renal function monitoring: Check serum creatinine and electrolytes before initiating therapy and periodically thereafter. - Electrolyte balance: Monitor potassium and sodium levels, especially when combined with other diuretics. - Pregnancy: Contraindicated in the second and third trimesters due to risk of fetal toxicity. - Elderly patients: Start with a lower dose and titrate slowly to avoid orthostatic hypotension. - Store at below 25°C: Keep in the original container, protect from moisture and light.

Olmesartan + HCTZ may influence   .

Major   g   t  ":"  "  " " ""  "" "" "" """"  "" "" "" "" """ " """" """"""""""""""""""""""""""""""""

Moderate  t """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""

"""  " "" "" """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""",

""  """""""""""""""""""",\